BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhao S, Allis CD, Wang GG. The language of chromatin modification in human cancers. Nat Rev Cancer 2021;21:413-30. [PMID: 34002060 DOI: 10.1038/s41568-021-00357-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 37] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Ning Y, Deng C, Li C, Peng W, Yan C, Ran J, Chen W, Liu Y, Xia J, Ye L, Wei Z, Xiang T. PCDH20 inhibits esophageal squamous cell carcinoma proliferation and migration by suppression of the mitogen-activated protein kinase 9/AKT/β-catenin pathway. Front Oncol 2022;12:937716. [DOI: 10.3389/fonc.2022.937716] [Reference Citation Analysis]
2 Yang C, Yu T, Lin Q. A signature based on chromatin regulation and tumor microenvironment infiltration in clear cell renal cell carcinoma. Epigenomics 2022. [PMID: 36154213 DOI: 10.2217/epi-2022-0202] [Reference Citation Analysis]
3 Shen M, Demers L, Bailey SD, Labbé DP. To bind or not to bind: Cistromic reprogramming in prostate cancer. Front Oncol 2022;12:963007. [DOI: 10.3389/fonc.2022.963007] [Reference Citation Analysis]
4 Sharda A, Humphrey TC. The role of histone H3K36me3 writers, readers and erasers in maintaining genome stability. DNA Repair (Amst) 2022;119:103407. [PMID: 36155242 DOI: 10.1016/j.dnarep.2022.103407] [Reference Citation Analysis]
5 Bruhn C, Bastianello G, Foiani M. Cancer cell histone density links global histone acetylation, mitochondrial proteome and histone acetylase inhibitor sensitivity. Commun Biol 2022;5:882. [PMID: 36030322 DOI: 10.1038/s42003-022-03846-3] [Reference Citation Analysis]
6 Sun H, Xi M, Jin Q, Zhu Z, Zhang Y, Jia G, Zhu G, Sun M, Zhang H, Ren X, Zhang Y, Xu Z, Huang H, Shen J, Li B, Ge G, Chen K, Zhu W. Chemo- and Site-Selective Lysine Modification of Peptides and Proteins under Native Conditions Using the Water-Soluble Zolinium. J Med Chem . [DOI: 10.1021/acs.jmedchem.2c00937] [Reference Citation Analysis]
7 Ma G, Gong T, Liu Z. Targeting Aberrant Histone Posttranscription Modification Machinery in Esophageal Squamous Cell Carcinoma: Current Findings and Challenges. Research 2022;2022:1-3. [DOI: 10.34133/2022/9814607] [Reference Citation Analysis]
8 Li Z, Zhao B, Qin C, Wang Y, Li T, Wang W. Chromatin Dynamics in Digestive System Cancer: Commander and Regulator. Front Oncol 2022;12:935877. [DOI: 10.3389/fonc.2022.935877] [Reference Citation Analysis]
9 Chandra B, Kriwacki R. Charting the human disease condensate dysregulome. Dev Cell 2022;57:1677-9. [PMID: 35901780 DOI: 10.1016/j.devcel.2022.07.001] [Reference Citation Analysis]
10 Sehrawat P, Shobhawat R, Kumar A. Catching Nucleosome by Its Decorated Tails Determines Its Functional States. Front Genet 2022;13:903923. [DOI: 10.3389/fgene.2022.903923] [Reference Citation Analysis]
11 Cheng M, Yang Q, Liu Y, Zhao M, Du X, Sun J, Shu W, Huang Z, Bi J, Xu X, Du H. SETD3 Methyltransferase Regulates PLK1 Expression to Promote In Situ Hepatic Carcinogenesis. Front Oncol 2022;12:882202. [DOI: 10.3389/fonc.2022.882202] [Reference Citation Analysis]
12 Kim HJ, Moon SJ, Hong S, Won HH, Kim JH. DBC1 is a key positive regulator of enhancer epigenomic writers KMT2D and p300. Nucleic Acids Res 2022:gkac585. [PMID: 35801925 DOI: 10.1093/nar/gkac585] [Reference Citation Analysis]
13 Shin DS, Park K, Garon E, Dubinett S. Targeting EZH2 to overcome the resistance to immunotherapy in lung cancer. Seminars in Oncology 2022. [DOI: 10.1053/j.seminoncol.2022.06.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Liu S, Tang W, Cao J, Shang M, Sun H, Gong J, Hu B. A Comprehensive Analysis of HAVCR1 as a Prognostic and Diagnostic Marker for Pan-Cancer. Front Genet 2022;13:904114. [PMID: 35754803 DOI: 10.3389/fgene.2022.904114] [Reference Citation Analysis]
15 Molenaar TM, van Leeuwen F. SETD2: from chromatin modifier to multipronged regulator of the genome and beyond. Cell Mol Life Sci 2022;79. [DOI: 10.1007/s00018-022-04352-9] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Liu D, Benzaquen J, Morris LGT, Ilié M, Hofman P. Mutations in KMT2C, BCOR and KDM5C Predict Response to Immune Checkpoint Blockade Therapy in Non-Small Cell Lung Cancer. Cancers (Basel) 2022;14:2816. [PMID: 35681795 DOI: 10.3390/cancers14112816] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Shirane K. The dynamic chromatin landscape and mechanisms of DNA methylation during mouse germ cell development. Genes Genet Syst 2022;97:3-14. [PMID: 35431282 DOI: 10.1266/ggs.21-00069] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Pete S, Roy N, Kar B, Paira P. Construction of homo and heteronuclear Ru(II), Ir(III) and Re(I) complexes for target specific cancer therapy. Coordination Chemistry Reviews 2022;460:214462. [DOI: 10.1016/j.ccr.2022.214462] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
19 Fu J, Qin W, Tong Q, Li Z, Shao Y, Liu Z, Liu C, Wang Z, Xu X. A novel DNA methylation-driver gene signature for long-term survival prediction of hepatitis-positive hepatocellular carcinoma patients. Cancer Med 2022. [PMID: 35637633 DOI: 10.1002/cam4.4838] [Reference Citation Analysis]
20 Yamaguchi K, Chen X, Oji A, Hiratani I, Defossez PA. Large-Scale Chromatin Rearrangements in Cancer. Cancers (Basel) 2022;14:2384. [PMID: 35625988 DOI: 10.3390/cancers14102384] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Sanchez A, Buck-Koehntop BA, Miller KM. Joining the PARty: PARP Regulation of KDM5A during DNA Repair (and Transcription?). Bioessays 2022;:e2200015. [PMID: 35532219 DOI: 10.1002/bies.202200015] [Reference Citation Analysis]
22 Li D, Yu X, Kottur J, Gong W, Zhang Z, Storey AJ, Tsai YH, Uryu H, Shen Y, Byrum SD, Edmondson RD, Mackintosh SG, Cai L, Liu Z, Aggarwal AK, Tackett AJ, Liu J, Jin J, Wang GG. Discovery of a dual WDR5 and Ikaros PROTAC degrader as an anti-cancer therapeutic. Oncogene 2022. [PMID: 35525905 DOI: 10.1038/s41388-022-02340-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
23 Bjune JI, Strømland PP, Jersin RÅ, Mellgren G, Dankel SN. Metabolic and Epigenetic Regulation by Estrogen in Adipocytes. Front Endocrinol (Lausanne) 2022;13:828780. [PMID: 35273571 DOI: 10.3389/fendo.2022.828780] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
24 Thum T. Orchestration of vascular smooth muscle cell plasticity using epigenetic therapy. Eur Heart J 2022:ehac200. [PMID: 35452116 DOI: 10.1093/eurheartj/ehac200] [Reference Citation Analysis]
25 Hu H, Du J. Structure and mechanism of histone methylation dynamics in Arabidopsis. Curr Opin Plant Biol 2022;67:102211. [PMID: 35452951 DOI: 10.1016/j.pbi.2022.102211] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Bröhm A, Schoch T, Grünberger D, Khella MS, Schuhmacher MK, Weirich S, Jeltsch A. The H3.3 G34W oncohistone mutation increases K36 methylation by the protein lysine methyltransferase NSD1. Biochimie 2022:S0300-9084(22)00069-4. [PMID: 35341929 DOI: 10.1016/j.biochi.2022.03.007] [Reference Citation Analysis]
27 Vaasjo LO. LncRNAs and Chromatin Modifications Pattern m6A Methylation at the Untranslated Regions of mRNAs. Front Genet 2022;13:866772. [DOI: 10.3389/fgene.2022.866772] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Dhayalan A, Jeltsch A. Special Issue “Structure, Activity, and Function of Protein Methyltransferases”. Life 2022;12:405. [DOI: 10.3390/life12030405] [Reference Citation Analysis]
29 Ren Z, Kim A, Huang YT, Pi WC, Gong W, Yu X, Qi J, Jin J, Cai L, Roeder RG, Chen WY, Wang GG. A PRC2-Kdm5b axis sustains tumorigenicity of acute myeloid leukemia. Proc Natl Acad Sci U S A 2022;119:e2122940119. [PMID: 35217626 DOI: 10.1073/pnas.2122940119] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
30 Spangler CJ, Yadav SP, Li D, Geil CN, Smith CB, Wang GG, Lee TH, McGinty RK. DOT1L activity in leukemia cells requires interaction with ubiquitylated H2B that promotes productive nucleosome binding. Cell Rep 2022;38:110369. [PMID: 35172132 DOI: 10.1016/j.celrep.2022.110369] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
31 Oscier D, Stamatopoulos K, Mirandari A, Strefford J. The Genomics of Hairy Cell Leukaemia and Splenic Diffuse Red Pulp Lymphoma. Cancers 2022;14:697. [DOI: 10.3390/cancers14030697] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Guo W, Wang H, Li C. Signal pathways of melanoma and targeted therapy. Signal Transduct Target Ther 2021;6:424. [PMID: 34924562 DOI: 10.1038/s41392-021-00827-6] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
33 Chen Y, Wang Y. Mapping histone modification-dependent protein interactions with chemical proteomics. Trends Biochem Sci 2021:S0968-0004(21)00241-3. [PMID: 34872818 DOI: 10.1016/j.tibs.2021.11.002] [Reference Citation Analysis]
34 Sun L, Lv S, Song T. O-GlcNAcylation links oncogenic signals and cancer epigenetics. Discov Onc 2021;12. [DOI: 10.1007/s12672-021-00450-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
35 Boon R. Metabolic Fuel for Epigenetic: Nuclear Production Meets Local Consumption. Front Genet 2021;12:768996. [PMID: 34804127 DOI: 10.3389/fgene.2021.768996] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
36 Vann KR, Vishweshwaraiah YL, Dokholyan NV, Kutateladze TG. Searching for methyllysine-binding aromatic cages. Biochem J 2021;478:3613-9. [PMID: 34624071 DOI: 10.1042/BCJ20210106] [Reference Citation Analysis]
37 Török B, Fazekas CL, Szabó A, Zelena D. Epigenetic Modulation of Vasopressin Expression in Health and Disease. Int J Mol Sci 2021;22:9415. [PMID: 34502322 DOI: 10.3390/ijms22179415] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
38 Xu C, Meng F, Park KS, Storey AJ, Gong W, Tsai YH, Gibson E, Byrum SD, Li D, Edmondson RD, Mackintosh SG, Vedadi M, Cai L, Tackett AJ, Kaniskan HÜ, Jin J, Wang GG. A NSD3-targeted PROTAC suppresses NSD3 and cMyc oncogenic nodes in cancer cells. Cell Chem Biol 2021:S2451-9456(21)00393-7. [PMID: 34469831 DOI: 10.1016/j.chembiol.2021.08.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 9.0] [Reference Citation Analysis]
39 Kuang X, McAndrew MJ, Mustachio LM, Chen YC, Atanassov BS, Lin K, Lu Y, Shen J, Salinger A, Macatee T, Dent SYR, Koutelou E. Usp22 Overexpression Leads to Aberrant Signal Transduction of Cancer-Related Pathways but Is Not Sufficient to Drive Tumor Formation in Mice. Cancers (Basel) 2021;13:4276. [PMID: 34503086 DOI: 10.3390/cancers13174276] [Reference Citation Analysis]
40 Pietropaolo V, Prezioso C, Moens U. Role of Virus-Induced Host Cell Epigenetic Changes in Cancer. Int J Mol Sci 2021;22:8346. [PMID: 34361112 DOI: 10.3390/ijms22158346] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]